IN8BIO, INC. (INAB) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
In8 Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • In8 Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.24 M, a 44.4% increase year-over-year.
  • In8 Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $4.75 M, a 33.4% increase year-over-year.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.37 M, a 26% increase from 2022.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.47 M, a 58% increase from 2021.
  • In8 Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.2 M, a 515% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.75 M $1.24 M +$381 K +44.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.37 M $1.25 M +$330 K +35.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $4.04 M $1.24 M +$343 K +38.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.7 M $1.02 M +$135 K +15.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 $3.56 M $859 K +$95 K +12.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.47 M $922 K -$43 K -4.46% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $3.51 M $897 K +$420 K +88.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.09 M $884 K +$492 K +126% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 $2.6 M $764 K +$403 K +112% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 $2.2 M $965 K +$662 K +218% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.53 M $477 K +$461 K +2881% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.07 M $392 K +$372 K +1860% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 $700 K $361 K +$343 K +1906% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 $357 K $303 K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $16 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $20 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 $18 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.